Skip to main content

Table 2 Clinical parameters recorded in CHilSFree

From: Immune monitoring after pediatric liver transplantation – the prospective ChilSFree cohort study

Basic patient data

 Age

 Sex

 Weight & height at transplantation

 Primary diagnosis

 Comorbidities before transplantation

 Concomitant medication at time of transplantation

 Biochemistry and hematology before transplantation

Transplant-related data

 Indication for transplantation

 Type (split / whole liver) and weight of graft

 Living related transplantation

 Donor information: age, gender, cause of donor death

 Blood group compatibility

 HLA status recipient

Infection related data

 CMV and EBV status of donor and recipient

 EBV/CMV infection

Immunosuppression

 Use of basiliximab for induction; IS drugs and trough levels at every visit, changes in IS drugs and reason for changes

Complications

 Standardized documentation of portal vein stenosis, portal vein thrombosis, arterial stenosis, artherial thrombosis, sepsis, hepatic vein stenosis, biliary obstruction, bile leak, wound infection, prolonged ventilation, inotrope support, PTLD; additional documentation of “other” complications

Follow-up visits

 Weight, height, biochemistry, hematology, virology (viral load CMV / EBV), changes in immunosuppressive medication, immunosuppressive drugs (dose and trough level), additional medication, additional comments

Biopsy visits

 Results of liver biopsy (rejection none, mild, moderate, severe and RAI score)